The genetic basis of non-syndromic autosomal recessive forms of amelogenesis imperfecta (AI) is unknown. To evaluate five candidate genes for an aetiological role in AI. In this study 20 consanguineous families with AI were identified in whom probands suggested autosomal recessive transmission. Family members were genotyped for genetic markers spanning five candidate genes: AMBN and ENAM (4q13.3), TUFT1 (1q21), MMP20 (11q22.3-q23), and KLK4 (19q13). Genotype data were evaluated to identify homozygosity in affected individuals. Mutational analysis was by genomic sequencing. Homozygosity linkage studies were consistent for localisation of an AI locus in three families to the chromosome 4q region containing the ENAM gene. ENAM sequence analysis in families identified a 2 bp insertion mutation that introduced a premature stop codon in exon 10. All three probands were homozygous for the same g.13185_13186insAG mutation. These probands presented with a generalised hypoplastic AI phenotype and a class II openbite malocclusion. All heterozygous carriers of the g.13185_13186insAG mutation had localised hypoplastic enamel pitting defects, but none had AI or openbite. The phenotype associated with the g.13185_13186insAG ENAM mutation is dose dependent such that ARAI with openbite malocclusion segregates as a recessive trait, and enamel pitting as a dominant trait.
The genetic basis of non-syndromic autosomal recessive forms of amelogenesis imperfecta (AI) is unknown. To evaluate five candidate genes for an aetiological role in AI. In this study 20 consanguineous families with AI were identified in whom probands suggested autosomal recessive transmission. Family members were genotyped for genetic markers spanning five candidate genes: AMBN and ENAM (4q13.3), TUFT1 (1q21), MMP20 (11q22.3-q23), and KLK4 (19q13). Genotype data were evaluated to identify homozygosity in affected individuals. Mutational analysis was by genomic sequencing. Homozygosity linkage studies were consistent for localisation of an AI locus in three families to the chromosome 4q region containing the ENAM gene. ENAM sequence analysis in families identified a 2 bp insertion mutation that introduced a premature stop codon in exon 10. All three probands were homozygous for the same g.13185_13186insAG mutation. These probands presented with a generalised hypoplastic AI phenotype and a class II openbite malocclusion. All heterozygous carriers of the g.13185_13186insAG mutation had localised hypoplastic enamel pitting defects, but none had AI or openbite. The phenotype associated with the g.13185_13186insAG ENAM mutation is dose dependent such that ARAI with openbite malocclusion segregates as a recessive trait, and enamel pitting as a dominant trait.
T he amelogenesis imperfectas (AI) are a clinically and aetiologically heterogeneous group of heritable disorders characterised by qualitative or quantitative anomalies of enamel development. While syndromic and non-syndromic forms of AI are reported, non-syndromic forms are the most prevalent. 1 2 Although multiple classifications systems have been proposed for this condition, our current understanding of its aetiology does not allow the development of a robust nosology to account for the phenotypic variability observed. [3] [4] [5] Both X linked and autosomal transmission of nonsyndromic forms of AI are well documented. [6] [7] [8] [9] Most forms of X linked AI are caused by mutation of the amelogenin gene, (AMELX 10 ). 11 The most common autosomal forms of AI show dominant transmission. Genetic linkage studies indicate that at least two distinct autosomal loci are responsible for dominant forms of AI, with some cases caused by enamelin (ENAM 12 ) gene mutations. 5 13-17 Identification of genes responsible for X linked and autosomal dominant forms of AI has contributed to a better understanding of the disease pathogenesis, and in some cases, genotype-phenotype correlations are emerging. 18 In contrast to the successes in identifying the genetic basis of autosomal dominant and X linked forms of AI, genetic studies have not identified or localised genetic loci for nonsyndromic forms of autosomal recessive AI (ARAI). Based on biological function and tissue expression, five candidate genes have been proposed for autosomal forms of AI, including ameloblastin (AMBN), enamelin (ENAM), tuftelin (TUFT1), enamelysin (MMP20), and kallikrein 4 (KLK4). 14 19-24 To evaluate support for or against linkage of these candidate loci with non-syndromic ARAI, we undertook homozygosity linkage studies in 20 nuclear families. In this paper we report identification of a novel ENAM mutation in probands from three families. Homozygous carriers of this novel mutation show AI and openbite malocclusion, while heterozygous carriers have only a mild localised enamel pitting phenotype.
METHODS

Pedigrees and diagnosis
Affected individuals were identified by proband ascertainment from dental clinics at the School of Dentistry, University of Istanbul, Istanbul, Turkey in accordance with institutional review board approval from the University of Istanbul and the University of Pittsburgh. Available family members had an oral examination and dental radiographs to characterise the AI phenotype when present. The presence of the disorder was established by generalised yellow-brown discolouration of the teeth, decreased enamel mineralisation, and pathological loss of enamel. Using modifications of clinical criteria previously proposed by Witkop, 1 affected individuals were classified into one of four groups: hypoplastic; hypomaturation; hypocalcified; and hypomaturation/ hypoplasia with taurodontism. 3 In addition to oral examinations, complete medical histories were taken to identify any additional clinical findings that would be consistent with syndromic conditions. Individuals with syndromic presentations of AI were excluded from the analyses.
Cephalometric and panoramic radiographs, photographic records, and dental casts were obtained to characterise the presence of skeletal openbite malocclusion in individuals with clinically evident openbite. Standard lateral cephalography was undertaken using a Cranex-3+Ceph at 10 mA and 81 kV (Cranex Co, Helsinki, Finland). Conventional cephalometric landmarks were identified and 15 angular and 15 linear measurements were made. 25 Negative values for the recordings of overbite represent a dentoalveolar anterior openbite. The facial ratio expressed by the relation between upper face height and total face height was calculated from the formula N2ANS/N2Me6100, where N-ANS = mid facial height and N-Me = total face height.
Molecular genetic analyses
DNA marker analysis
Genomic DNA was isolated from whole blood by standard techniques using the QIAamp blood kit (Qiagen). Family members were genotyped for STRP (short tandem repeat polymorphism) genetic markers spanning the five autosomal candidate loci, selected on the basis of their role in enamel development. Three gene loci (TUFT1, MMP20, and KLK4) were genotyped using previously described STRPs. 17 Although the AMBL and ENAM loci have been mapped to chromosome 4q21, their precise location and position relative to each other has only recently been determined. 17 Three novel STRP loci spanning the AMBL and ENAM loci were identified using the tandem repeats finder program. 26 Oligonucleotide primers used to amplify these loci were: 719M16: F 59-CCATTAGAG-CTATTTCAGATA-39; R 59-CACAAAGCCAGAGAA ACAT-TA -39; AMB: F 59-GATTCAGCATCAACTTCCACAGAG-39: R 59-CCAGCCTGAGCTTGTCTTAAAGAT-39; and 92H22: F 59-CTCGCTTTGGGTTTCTCTGATGTT-39, R 59-CTGGCA ATGT-GGGCTGRCTCTACA-39.
Marker loci were amplified by polymerase chain reaction, using fluorescence labelled primers, permitting genotyping by conventional methods. 27 Single nucleotide polymorphisms (SNPs) were identified and localised within the AMBN-ENAM region of chromosome 4q13, based on the alignment of candidate SNPs with the physical map developed in our laboratory. 17 SNPs were identified on the basis of sequence data from public and propriety databases (ABI , http:// www.appliedbiosystems.com/apps/) and the NCBI SNP database (http://www.ncbi.nlm.nih.gov/). SNP assays were obtained from Applied Biosystems (ABI) and were genotyped using an ABI 7900HT (Applied Biosystems). Allele calling was done using the 7900HT software.
ENAM mutation analysis
The exons and exon/intron boundaries of the enamelin gene were amplified as previously described. 5 Extracted amplicons were sequenced in both directions using ABI Big Dye terminator chemistry and an ABI 3700 DNA analyser (Applied Biosystems). Groups of 50 unaffected Turkish control individuals (100 alleles) and 50 unaffected control individuals (100 chromosomes) of European and African descent were also sequenced.
RESULTS
Clinical findings
Identification of probands with AI resulted in the ascertainment of 20 nuclear families with a history of parental consanguinity. The distribution of probands into AI subtypes was: hypoplastic (10 families); hypomaturation (four families); hypocalcified (one family); and hypomaturation/ hypoplasia with taurodontism (five families). We studied 106 family members from these 20 families (20 probands, 40 parents, six affected siblings, 24 unaffected siblings, and 16 cousins, aunts, uncles, and grandparents).
Genotyping results
Genotype data were not consistent with homozygosity for genetic marker loci spanning the chromosome 1q21 (TUFT1), 11q22.3-q23 (MMP20), and 19q13.3-q13.4 (KLK4) candidate intervals in the affected probands from any of the 20 families. Genotyping results indicated that three probands (family 2, II-4; family 7, VI-1; family 12, IV-1) were homozygous for STRP markers from the chromosome 4q (AMBN-ENAM) candidate interval (fig 1) . Genotyping for eight SNP markers spanning a genetic interval of ,50 kb containing the ENAM locus indicated all three probands were homozygous for an identical haplotype, refining the candidate interval to the ENAM locus. Genotype data from none of the other 17 families were supportive of homozygosity of genetic marker loci spanning the chromosome 4q13.3 candidate interval in the affected probands.
ENAM mutation analysis
Sequencing of the enamelin gene showed that the affected probands from families 2, 7, and 12 were all homozygous for a 2 bp insertion mutation in exon 10 of ENAM (fig 2) . The resultant frameshift codes for 26 novel amino acids and introduces a premature termination at codon 448.
According to the nomenclature guidelines for ENAM mutations, 5 this mutation is designated as g.13185_13186insAG (c.1258_1259insAG; p.P422fsX448). All six parents and three siblings of these probands were heterozygous carriers of the g.13185_13186insAG mutation. Of 12 additional family members available for study, three were carriers of the g.13185_13186insAG mutation. Sequence analysis of the ENAM exon 10 did not identify this g.13185_13186insAG mutation in any of 50 unrelated unaffected Turkish controls (100 alleles) or 50 unrelated unaffected controls of European and African descent (100 alleles). Sequence analysis of all coding regions and intronexon boundaries of the ENAM gene undertaken for the 17 probands from other families which were not consistent for linkage to this candidate region did not identify the g.13185_13186insAG mutation or any other ENAM mutation.
Genotype-phenotype correlations
Clinical findings in the three probands homozygous for the g.13185_13186insAG mutation were consistent with a severe generalised AI phenotype that appeared both clinically hypoplastic and radiographically undermineralised (fig 3) . Taurodontism was not present in any individuals, and no anomalies of dental pulp or root structures were radiographically evident ( fig 3C) . In addition to AI, these three probands were also noted to have a clinically evident openbite type malocclusion ( fig 3B) . Openbite diagnosis was confirmed by cephalometric analysis (table 1). All three probands (family 2, II-4; family 7, VI-1; family 12, II-1) had a retrognathic mandibular position (SNB angles 70˚-73˚), class II malocclusion (ANB angles 5˚to 7.5˚), and vertical relations (indicated by the sum of the saddle, articular, and gonial angles) were greater than the normal values. In all three probands, Y axis angles, FMA angles, and the angles between maxillary and mandibular planes were greater than the normal values. The Jarabak ratio indicated that these three probands were in high angle pattern with anterior openbite. Thus all three probands showed AI and cephalometric features of skeletal openbite. No other family members had clinical openbite.
Clinical and radiographic examination of teeth from relatives of the affected probands showed that none had a clinical diagnosis of AI and none presented with a clinical openbite malocclusion. However, all the probands' parents, three siblings, and three of their relatives were found to have localised circumscribed discrete areas of enamel hypoplasia consistent with a clinical diagnosis of enamel pitting (fig 4) . All individuals with these localised enamel defects were heterozygous carriers of the ENAM mutation (g.13185_13186insAG mutation/wild-type). Localised circumscribed enamel defects were found on the buccal surfaces of the anterior teeth, and on the occlusal surfaces and cusps of the canines, premolars, and molars (fig 4) . Local enamel defects were found only in family members who were heterozygous for the ENAM mutation.
DISCUSSION
In these analyses, genetic linkage studies were consistent for localisation of an ARAI locus to the AI candidate region of chromosome 4q13.3 in three of the 20 families studied. Genomic DNA sequence analysis of the three affected probands identified a two base pair insertion mutation in exon 10 of the ENAM gene. The murine ENAM gene has 10 exons. The human ENAM gene has been described as having nine exons. The human cDNA lacked the sequence corresponding to murine exon 2. However, the human ENAM gene homologous sequence is flanked by appropriate splicing junctions, raising the possibility that alternative splicing of this exon occurs. An analogous situation is seen with amelogenin, where 99% of the transcripts lack exon 4. Table 2 presents the known ENAM mutations in the more robust standardised ENAM nomenclature, 5 to make it easy for readers to compare mutations from various studies.
On the basis of nomenclature guidelines, 5 28 we have designated the insertion between nucleotides 13 185 and 13 186 in the genomic sequence (g.13185_13186insAG) and between nucleotides 1258 and 1259 in the ENAM cDNA sequence (c.1258_1259insAG). The codon for amino acid L420 is changed from CTG to CTA, which still encodes leucine, but the additional nucleotides produce a frameshift and an early termination of the protein. The chimeric 447-amino acid protein consists of 421 N-terminal amino acids followed by 26 replaced amino acids and a premature stop codon at codon 448 (p.P422fsX448). This mutation dramatically alters the protein cleavage products of the enamelin gene. The g.13185_13186insAG ENAM mutation was not present in any of 200 control chromosomes from unrelated individuals without enamel defects, suggesting this allele is not a common variant of the enamelin gene. The segregation of this mutation in three families with enamel anomalies, and the lack of this mutation in 200 control chromosomes from unaffected individuals, supports a causal role for this mutation with enamel defects. Based on clinical and laboratory findings, we propose that the g.13185_13186insAG ENAM mutation segregates localised hypoplastic enamel pitting as a dominant trait, and hypoplastic AI with a skeletal class II openbite malocclusion as a recessive trait.
Demonstration of an ENAM mutation causing ARAI provides an explanation for the often reported sporadic occurrence of this condition and indicates that such cases are compatible with autosomal recessive transmission of an underlying gene defect. The current findings also show genetic heterogeneity for autosomal recessive AI. The generality of ENAM mutations in ARAI is unknown, yet the fact that no other ENAM mutations were found in the remaining 17 probands, and the lack of support for allelic homozygosity for markers throughout this genetic interval in these probands, suggests that other autosomal loci are responsible for non-syndromic ARAI. While the three families with the g.13185_13186insAG ENAM mutation were not known to be related, the common haplotype shared by all three suggests the mutation has been inherited ''identical by descent'' from a common ancestor.
Clinical findings associated with the g.13185_13186insAG ENAM mutation are dose dependent. Dose dependent increases in phenotype severity are known to be associated with certain mutations (for example, for familial hypercholesterolaemia associated with mutations in the low density lipoprotein receptor gene 29 30 ). The interesting clinical correlate of the ENAM g.13185_13186insAG mutation is that the mild enamel pitting phenotype would not be considered a mild form of AI. Enamel pitting is a recognised clinical phenotype, but the mild form seen in carriers of the g.13185_13186insAG mutation has not previously been associated with AI. The dose dependent clinical findings related to the g.13185_13186insAG mutation have implications for understanding the role of enamelin in enamel development and also for AI nosology. The enamel specific protein, enamelin, is highly conserved among animals and comprises approximately 5-10% of enamel proteins. 31 The human enamelin signal peptide has 39 amino acids and the secretory protein has 1103. 23 Enamelin is secreted as a precursor that undergoes proteolytic processing to yield several functional cleavage products. Enamelin cleavage products have been extensively studied in human and porcine models. 32 33 Results of immunolocalisation studies suggest that the 142 and 89 kDa enamelin products are found in newly formed enamel, whereas the 32 kDa enamelin and low molecular weight proteins are detected in the inner enamel layer. 34 Further processing of the 142 kDa enamelin produces an 89 kDa and a 34 kDa cleavage product. Subsequent cleavage of the 89 kDa enamelin produces a 25 kDa species. The various enamelin cleavage products may have different roles in enamel development, as evidenced by their differential compartmentalisation in developing enamel. 35 Among the cleavage products, the structure of the 32 kDa enamelin is well characterised and is reported to be N-linked glycosylated at three sites and phosphorylated at two serines. 36 It is particularly stable, absorbs strongly onto apatite crystals in developing enamel, and accumulates to comprise about 1% of the total enamel protein. 37 Glycosylation generally increases the acidity of a protein, which could act to increase its affinity for hydroxyapatite. The interaction of enamelin and amelogenin may contribute to the development of a well organised enamel structure by supporting a framework of prism rods. 38 A recent report that amelogenin binds to N-acetylglucosamine illustrates the potential importance of such proteinprotein interactions in enamel development. 39 Interestingly, a single amino acid mutation in amelogenin is sufficient to destroy its binding affinity to N-acetylglucosamine and cause X linked AI. 40 Our current findings extend to four the number of enamelin gene mutations reported to be responsible for AI (table 2). The three enamelin gene mutations previously reported all cause AI that segregates as an autosomal dominant trait. These three mutations occur 59 from the g.13185_13186insAG mutation. The local hypoplastic form of autosomal dominant AI (ADAI) found with the previously reported g.2382A.T (p.K53X) mutation most probably results from haploinsufficiency for the various enamelin cleavage products (32 kDa, 25 kDa, and 34 kDa). 16 The other two previously reported ENAM mutations are believed to affect the 32 kDa cleavage product, resulting in a generalised form of smooth hypoplastic AI. 5 14 15 In these later cases, there is an overall reduction in the amount of enamel produced. Whether the g.6395G.A and g.8344delG mutations act through haploinsufficiency or a dominant negative effect is unknown, but both affect the 32 kDa cleavage product, and the associated AI phenotype segregates as a dominant trait. In contrast, the currently reported g.13185_13186insAG mutation occurs downstream of the 32 kDa cleavage site and is predicted to result in a truncated protein that is 695 amino acids shorter than the wild-type protein of 1142 amino acids. Thus carriers for the mutation would produce normal amounts of the 32 kDa enamelin but only 50% of the 25 kDa and 34 kDa cleavage products.
In contrast to the dominant transmission of the AI clinical phenotypes reported for the previous ENAM mutations, the g.13185_13186insAG mutation does not cause AI when present in the heterozygous state. Teeth of carriers of this mutation have only a variable number of localised circumscribed areas of hypoplastic enamel that appear as pits approximately 1-2 mm in diameter and depth. The colour of the enamel in these defective pits, as well as in areas of normal enamel thickness, is normal. Yet the severe generalised AI phenotype observed in individuals homozygous for this mutation suggests that the 25 kDa and 34 kDa enamelins are crucial for normal enamel development.
Localised circumscribed hypoplastic enamel defects (LHED) that appear as enamel pitting were present in all heterozygous carriers of the g.13185_13186insAG ENAM mutation. This enamel pitting was present on the labial surfaces of the incisors, and more commonly on the labial surfaces of the canines, as well as on the occlusal surfaces of the canines and posterior teeth (fig 4) . Similar areas of enamel hypoplasia were not present in family members without the mutation. This is the first identification of a specific gene mutation associated with this limited disturbance of enamel development. The generality of this specific gene mutation for such hypoplastic enamel defects is unknown, but raises the possibility that other allelic ENAM mutations, as well as mutations of different enamel related genes, may cause LHED. This finding has implications for the identification of aetiological factors associated with local enamel defects.
As enamel defects provide a permanent record of exposure to factors that may interfere with normal enamel development, localised defects have been studied in a variety of human and primate populations. LHED have been used as an indicator of lifestyle and stress in human and ape populations by anthropologists. [41] [42] [43] [44] While the patterns in LHPC expression are similar in humans and apes, the prevalence of such defects varies with different study populations. The prevalence of discrete areas of defective enamel formation varies in prehistoric populations (rare in Neanderthal, .40% in upper paleolithic and neolithic) and current human populations (,1% to .56%). [45] [46] [47] [48] [49] The prevalence of enamel defects also varies among apes, from 0.0% in gibbons to 61.5% in bonobos and .85% in orangutans and gorillas. [50] [51] [52] While diverse aetiological factors including diet, stress, fever, injury, infection, and genetics have been proposed for localised enamel defects, most emphasis has been placed on nongenetic factors. The current findings suggest that mutations in genes important in amelogenesis may play a significant role in the aetiology of local enamel hypoplasia, suggesting that genetic factors are more important in LHED aetiology than previously believed. Recessive mutations in both human and ape populations could account for the variance in enamel defect prevalence reported. An anterior openbite malocclusion, generally considered to be of skeletal origin, is a frequent associated finding in AI. [53] [54] [55] [56] [57] [58] [59] [60] In the current study, individuals homozygous for the g.13185_13186insAG mutation were noted to have an anterior openbite malocclusion as well as AI. Skeletal anterior openbite arises because of disharmony in the vertical relation between the maxillary and mandibular bases, characterised by increased gonial and mandibular plane angles. Results of lateral cephalometric analysis were consistent with a class II malocclusion in the three probands homozygous for the g.13185_13186insAG mutation (table 1) . This malocclusion was not present in any other family members. While some believe that the coexistence of AI and openbite malocclusion may be attributed to pleiotropic action of the AI gene(s) influencing the growth of the craniofacial skeleton, 55 61 62 others contend that openbite reflects the influence of modifying genes or environmental factors. 58 Witkop argued that true AI involved only enamel defects, attributing the frequent association of anterior openbite with AI to a locally acting mechanism whereby thermally sensitive teeth lead to a tongue thrusting habit which acts as a local impediment to alveolar growth, producing anterior openbite. 63 64 Given AI is rare and anterior openbite is uncommon, occurring in around 2% of teenagers, 65 the frequent occurrence of both conditions appears more than coincidental. The relation of the underlying gene of major effect mutation to the observed malocclusion in AI is unclear, yet the association of openbite malocclusion with a large number of AI cases suggests an aetiological association. In contrast to bones in the rest of the body that are derived from the mesoderm of the primitive streak, in the craniofacial complex the neural crest cells originating from the ectoderm give rise to the ectomesenchyme, from which much of the skull is formed. 55 Various different classification systems have been proposed for AI, with most based on the clinical phenotype of teeth and the mode of Mendelian transmission. 1 3 4 However, with more than 14 clinical types of non-syndromic AI, the clinical variability seen within some families, and the variable clinical findings involving AI and openbite malocclusion, classifications based on clinical findings in AI can be extremely cumbersome. 3 5 15 66 67 Identification of additional gene loci responsible for AI should improve our understanding of the underlying physiological disturbances, and help to explain the phenotypic variability. The emerging genotype-phenotype correlations for ENAM mutations indicate that a fundamental understanding of how each specific gene mutation affects enamel development will be necessary to provide the appropriate information to develop a robust nosology with clinical value. 68 
